Search research articles
Contact Us
Filters
Showing results (711-720 of 974) with videos related to
Page
of 98
Sort By:
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2019
Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis
Xiao Wei, Yi Liu, Cheng Gong, et al.
Plos One
|
April 12, 2014
A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs
Qinglei Gao, Caihong Chen, Teng Ji, et al.
Plos One
|
September 18, 2012
Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers
Xiangyi Ma, Ling Xi, Danfeng Luo, et al.
Journal of the American Chemical Society
|
January 6, 2018
Hybrid Au-Ag Nanostructures for Enhanced Plasmon-Driven Catalytic Selective Hydrogenation through Visible Light Irradiation and Surface-Enhanced Raman Scattering
Zhen Yin, Ye Wang, Chuqiao Song, et al.
Nature Communications
|
May 5, 2023
Structure-dependence and metal-dependence on atomically dispersed Ir catalysts for efficient n-butane dehydrogenation
Xiaowen Chen, Xuetao Qin, Yueyue Jiao, et al.
Journal of the American Chemical Society
|
October 4, 2023
Light-Reinforced Key Intermediate for Anticoking To Boost Highly Durable Methane Dry Reforming over Single Atom Ni Active Sites on CeO<sub>2</sub>
Zhiqiang Rao, Kaiwen Wang, Yuehan Cao, et al.
Nature Communications
|
June 29, 2024
Pulsed laser induced plasma and thermal effects on molybdenum carbide for dry reforming of methane
Yue Li, Xingwu Liu, Tong Wu, et al.
Oncology Letters
|
June 8, 2017
Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
Xin Jin, Yong Fang, Yi Hu, et al.
Cell Death & Disease
|
June 9, 2017
Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming
Shujuan Sun, Jia Liu, Meisong Zhao, et al.
Genome Medicine
|
August 5, 2025
Blocking CXCR4<sup>+</sup> CD4<sup>+</sup> T cells reprograms T<sub>reg</sub>-mediated immunosuppression via modulating the Rho-GTPase/NF-κB signaling axis
Canhui Cao, Miaochun Xu, Ting Peng, et al.
Page
of 98
Search research articles
Search
Showing results (711-720 of 974) with videos related to
Sort By:
Page
of 98
Anti-Cancer Agents in Medicinal Chemistry
|
June 18, 2019
Correction: Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis
Xiao Wei, Yi Liu, Cheng Gong, et al.
Plos One
|
April 12, 2014
A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs
Qinglei Gao, Caihong Chen, Teng Ji, et al.
Plos One
|
September 18, 2012
Anti-tumor effects of the peptide TMTP1-GG-D(KLAKLAK)(2) on highly metastatic cancers
Xiangyi Ma, Ling Xi, Danfeng Luo, et al.
Journal of the American Chemical Society
|
January 6, 2018
Hybrid Au-Ag Nanostructures for Enhanced Plasmon-Driven Catalytic Selective Hydrogenation through Visible Light Irradiation and Surface-Enhanced Raman Scattering
Zhen Yin, Ye Wang, Chuqiao Song, et al.
Nature Communications
|
May 5, 2023
Structure-dependence and metal-dependence on atomically dispersed Ir catalysts for efficient n-butane dehydrogenation
Xiaowen Chen, Xuetao Qin, Yueyue Jiao, et al.
Journal of the American Chemical Society
|
October 4, 2023
Light-Reinforced Key Intermediate for Anticoking To Boost Highly Durable Methane Dry Reforming over Single Atom Ni Active Sites on CeO<sub>2</sub>
Zhiqiang Rao, Kaiwen Wang, Yuehan Cao, et al.
Nature Communications
|
June 29, 2024
Pulsed laser induced plasma and thermal effects on molybdenum carbide for dry reforming of methane
Yue Li, Xingwu Liu, Tong Wu, et al.
Oncology Letters
|
June 8, 2017
Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines
Xin Jin, Yong Fang, Yi Hu, et al.
Cell Death & Disease
|
June 9, 2017
Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming
Shujuan Sun, Jia Liu, Meisong Zhao, et al.
Genome Medicine
|
August 5, 2025
Blocking CXCR4<sup>+</sup> CD4<sup>+</sup> T cells reprograms T<sub>reg</sub>-mediated immunosuppression via modulating the Rho-GTPase/NF-κB signaling axis
Canhui Cao, Miaochun Xu, Ting Peng, et al.
Page
of 98